LTBR and hepatocellular carcinoma: In this study, we established primary and subcutaneous mouse models of hepatocellular carcinoma (HCC) featuring a CD4+ T cell-conditional knock-in (cKI) of Ltbr. Our findings indicated that this modification suppressed tumor growth by augmenting the Th17/Treg cell ratio.